Showing 6711-6720 of 6937 results for "".
- Lucid, Inc. Now Named Caliber IDhttps://practicaldermatology.com/news/20120926-lucid_inc_now_named_caliber_id/2459729/Lucid, Inc. announced that it is now operating under a new company name, Caliber Imaging & Diagnostics, Inc., or Caliber ID. Caliber ID has created an entirely new class of tools enabling physicians to image and diagnose skin disease in real tim
- New Survey: Rosacea Inflicts Physical Discomforthttps://practicaldermatology.com/news/20120925-new_survey_rosacea_inflicts_physical_discomfort/2459731/A recent survey conducted by the National Rosacea Society (NRS) shows that significant physical discomfort often accompanies the visible signs of rosacea. In the survey of 1,709 patients with rosacea, nearly 93 percent said they had experienced physical discomfort as a result of the disorder. A burn
- NeoStrata Launches SKIN ACTIVE Perfecting Peelhttps://practicaldermatology.com/news/20120918-neostrata_launches_skin_active_perfecting_peel/2459736/NeoStrata Company, Inc., the creators of the original glycolic acid peel, introduced the Perfecting Peel to SKIN ACTIVE, its line of antiaging skincare. SKIN ACTIVE Perfecting Peel is formulated with a 20% alpha hydroxy acid blend of 10% citric
- CMS Provider Call Today on EHRshttps://practicaldermatology.com/news/20120913-cms_provider_call_today_on_ehrs/2459740/The Centers for Medicare and Medicaid Services will host a 90-minute National Provider Call today, Sept. 13, to discuss the final rule for the Stage 2 electronic health records meaningful use program. The call is free, but prior registration is required.
- Valeant Acquires Medicis Pharmaceutical Corp. for $2.6 Billionhttps://practicaldermatology.com/news/20120904-valeant_acquires_medicis_pharmaceutical_for_26_billion/2459743/Valeant Pharmaceuticals announced an agreement to acquire Medicis Pharmaceutical for $44 per share in cash, in a deal worth approximately $2.6 billion. The transaction is expected to close in the first half of 2013 and has been approved by each company's board of directors. The combined operations w
- Plastic Surgeons Use ExtendCredit to Provide Financing Services for Patientshttps://practicaldermatology.com/news/20120830-plastic_surgeons_use_extendcredit_to_provide_financing_services_for_patients/2459744/Riverside Plastic Surgery and San Diego-based SpiritLift Plastic Surgery recently started using ExtendCredit.com, an online software platform for creating and managing in-house customer financing plans for small to mid-sized businesses. The two practices now use ExtendCredit's fully automated, onlin
- App Launched for Medical Entrepreneurshttps://practicaldermatology.com/news/20120824-app_launched_for_medical_entrepreneurs/2459746/The free Medical Entrepreneur App went live on the Apple Store this month. The app, developed by Steven M. Hacker, MD, provides healthcare providers and medical students with business intelligence and decision making tools before, duri
- ASDS Annual Meeting Sessions Announced, Early Registration Discounthttps://practicaldermatology.com/news/20120808-asds_annual_meeting_sessions_announced_early_registration_discount/2459754/The 2012 Annual Meeting of the American Society for Dermatologic Surgery (ASDS) will be held from October 11 to 14 in Atlanta, GA. The 65-plus scientific and educational sessions are divided into four comprehensive curriculum tracks: co
- CryoShape LTD Launches One-time Scar-freezing Treatmenthttps://practicaldermatology.com/news/20120802-cryoshape_ltd_launches_one-time_scar-freezing_treatment/2459758/CryoShape LTD introduced CryoShape, a new technology to reduce or eliminate keloid and hypertrophic scars, at the Aesthetic Plastic Surgery/Anti-Aging Medicine: The Next Generation Symposium in New York City July 20-22, 2012. The product uses a
- Sandoz Completes Acquisition of Fougera Pharmaceuticalshttps://practicaldermatology.com/news/20120727-sandoz_completes_acquisition_of_fougera_pharmaceuticals/2459760/Sandoz has completed its USD $1.525 billion acquisition of specialty dermatology company Fougera Pharmaceuticals. Combined with Sandoz's existing generic dermatology franchise, this acquisition positions Sandoz as the new #1 in generic dermatology